E
Clarivate Plc CLVT
$2.47 $0.052.07% NYSE
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

Company Overview

Clarivate Plc is a global information services and analytics company that provides trusted data, insights, and workflow solutions to accelerate innovation and informed decision-making. The company operates primarily in the intellectual property, life sciences, healthcare, and academic & government research industries. Clarivate’s core value proposition is enabling customers to identify, protect, and commercialize innovation, improve research outcomes, and make evidence-based strategic decisions across the innovation lifecycle.

Clarivate was formed in 2016 following the separation of the Intellectual Property & Science business from Thomson Reuters and subsequently rebranded as Clarivate Plc. The company expanded significantly through acquisitions, most notably the acquisition of CPA Global in 2020, which strengthened its position in intellectual property management and software. Clarivate has positioned itself as a mission-critical provider of proprietary data, analytics, and subscription-based solutions, with high customer retention driven by embedded workflows and long-term contracts.

Business Operations

Clarivate generates revenue primarily through subscription-based and recurring information services across several operating segments. Its major business segments include Intellectual Property, Life Sciences & Healthcare, and Academia & Government. Key products and platforms include Web of Science, Cortellis, Derwent, CompuMark, and MarkMonitor, which support patent analytics, trademark protection, drug development intelligence, regulatory insight, and academic research evaluation.

The company operates globally, serving multinational corporations, law firms, pharmaceutical and biotechnology companies, universities, research institutions, and government agencies. Clarivate controls extensive proprietary databases, analytics platforms, and software tools that are deeply integrated into customer workflows. Its operations include both domestic and international service delivery, supported by technology centers, research analysts, and customer support teams worldwide.

Strategic Position & Investments

Clarivate’s strategic direction focuses on simplifying and integrating complex data into end-to-end workflow solutions, expanding recurring revenue, and improving operational efficiency. Growth initiatives include product innovation within AI-enabled analytics, cloud-based platforms, and integrated IP and life sciences solutions. The company has emphasized cross-selling opportunities across its customer base following prior acquisitions and portfolio integration efforts.

Major strategic investments have included the acquisition of CPA Global, which significantly expanded Clarivate’s IP software and services capabilities, and earlier acquisitions that enhanced its life sciences and healthcare intelligence offerings. Clarivate continues to invest in emerging technologies such as advanced analytics, machine learning, and data interoperability to enhance customer decision-making and maintain competitive differentiation in high-value information markets.

Geographic Footprint

Clarivate is headquartered in London, United Kingdom, and maintains significant operational and commercial presence in North America, Europe, and Asia-Pacific. The company serves customers in more than 100 countries, with major offices and operations in the United States, United Kingdom, India, China, and Western Europe.

Its global footprint supports international research, intellectual property protection, and innovation ecosystems. Clarivate’s international operations are integral to its strategy, both as sources of revenue and as centers for data curation, analytics development, and client services, giving the company a broad and diversified geographic exposure.

Leadership & Governance

Clarivate is led by an executive team with experience across information services, technology, and global operations. The leadership emphasizes operational discipline, customer-centric innovation, and the delivery of high-quality, trusted data products that support long-term customer relationships and sustainable growth.

Key executives include:

  • Matthew J. Sacher – President and Chief Executive Officer
  • Jonathan Collins – Executive Vice President and Chief Financial Officer
  • Gordon Samson – President, Intellectual Property
  • Bar Veinstein – President, Academia & Government
  • Matt Gehl – President, Life Sciences & Healthcare

The company operates under a public company governance structure and is overseen by a Board of Directors responsible for strategic oversight, risk management, and alignment with shareholder interests.

Data complied by narrative technology. May contain errors

Top Tech Stocks
See All »
B
NVDA NASDAQ $170.67
B
AAPL NASDAQ $248.38
B
AVGO NASDAQ $302.49
Top Consumer Staple Stocks
See All »
B
WMT NASDAQ $123.57
B
Top Financial Stocks
See All »
B
B
JPM NYSE $289.76
B
V NYSE $298.81
Top Energy Stocks
See All »
Top Health Care Stocks
See All »
B
LLY NYSE $915.00
B
JNJ NYSE $243.88
B
AMGN NASDAQ $350.73
Top Real Estate Stocks
See All »
B
PLD NYSE $131.30